210-500
Endothelial Cell Basal Medium (500ml)
Synonym(s):
Primary Cell Culture Media
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
form
liquid
Quality Level
shelf life
1 yr
manufacturer/tradename
Cell Applications, Inc
shipped in
dry ice
storage temp.
−20°C
General description
Basal Medium without Growth Supplement
Application
Endothelial Cell Basal Medium (500ml) has been used in culturing of:
- human umbilical vein endothelial cells
- human coronary artery endothelial cells
- human pulmonary artery endothelial cells
Quality
Each lot was tested for the ability to support plating, spreading and proliferation
Preparation Note
contained in protocol
Storage Class
12 - Non Combustible Liquids
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Immunopharmacology and immunotoxicology, 39(2), 55-58 (2017-02-06)
The popular murine macrophage cell line, RAW 264.7, is often used to initially screen natural products for bioactivity and to predict their potential effect in vivo or on primary cells. The cell line response is considered to reflect the potential
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 140, 111788-111788 (2021-06-02)
Complex regional pain syndrome (CRPS) is a chronic pain condition characterized by inflammation and debilitating pain. CRPS patients with pain refractory to more conventional analgesics can be treated with subanesthetic doses of ketamine. Our previous studies found that poor responders
International journal of molecular sciences, 21(21) (2020-11-01)
Although saphenous veins (SVs) are commonly used as conduits for coronary artery bypass grafting (CABG), internal thoracic artery (ITA) grafts have significantly higher long-term patency. As SVs and ITA endothelial cells (ECs) have a considerable level of heterogeneity, we suggested
International journal of chronic obstructive pulmonary disease, 16, 1329-1345 (2021-05-20)
Etanercept (ETN), a tumor necrosis factor-α (TNF-α) inhibitor, has been applied in the treatment of many diseases. However, whether it has effects on chronic obstructive pulmonary disease (COPD) and its interaction with tumor necrosis factor receptor 1 (TNFR1) remained unknown.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service